Beyond their efficacy as antihyperglycemic agents, GLP-1 RAs have demonstrable cardiovascular and renal benefits, strengthening the recommendation of using this therapeutic class in individuals with T2DM at high cardiovascular risk [13]. Here, GLP1R is linked to type 2 diabetes mellitus.